BridgeMD
New treatment option for Chronic Migraine
Official title Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult
ClinicalTrials.gov ID: NCT06322407
What this study is testing
What is standardized drug treatment?
standardized drug treatment is an investigational medicine, given as an once-weekly, being studied as a potential treatment for chronic migraine.
Also referred to as topiramate plus ibuprofen.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To assess the 6-months effects and safety of stellate ganglion block(SGB) for Chronic Migraine (CM) patients who failure to undergo preventive therapy and are seeking a more suitable non-pharmacological therapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age from 18 to 65 years;
- Diagnosed with CM according to the International Classification of Headache Disorders, 3rd (ICHD-3) criteria [Headache Classification Committee of...
- not received prior prophylactic migraine treatment or, due to lack of how well it works or side effects, had failed or had not been suitable for up...
You likely can't join if
- BMI \ 35 kg/m2；
- Previous SGB treatment；
- History of other neurological disorders；
- History of severe cardiopulmonary, hepatic or renal dysfunction；
- History of allergies to any of the study drugs；
- Patients with chronic use of opioids；
See the full eligibility criteria
- Age from 18 to 65 years;
- Diagnosed with CM according to the International Classification of Headache Disorders, 3rd (ICHD-3) criteria [Headache Classification Committee of the International Headache Society (IHS). The International...
- not received prior prophylactic migraine treatment or, due to lack of how well it works or side effects, had failed or had not been suitable for up to three previous prophylactic treatments from the following...
- BMI \ 35 kg/m2；
- Previous SGB treatment；
- History of other neurological disorders；
- History of severe cardiopulmonary, hepatic or renal dysfunction；
- History of allergies to any of the study drugs；
- Patients with chronic use of opioids；
- Preoperative coagulation abnormalities (activated partial thromboplastin time greater than 1.5 time normal value)；
- Infection or mass near the puncture site；
- Neck anatomic structural changes (caused by radiotherapy or surgery);
- Pregnant or breast feeding;
- Psychological disorders;
- Refusal to sign informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.